Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Use of monoclonal antibodies in renal transplantation.

van den Hoogen MW, Hilbrands LB.

Immunotherapy. 2011 Jul;3(7):871-80. doi: 10.2217/imt.11.72. Review.

3.
4.

Role of anti-interleukin-2 receptor antibodies in kidney transplantation.

Cibrik DM, Kaplan B, Meier-Kriesche HU.

BioDrugs. 2001;15(10):655-66. Review.

PMID:
11604047
5.

[Monoclonal interleukin-2 receptor antibodies and their use in clinical kidney transplantation: basiliximab and daclizumab].

Madsen M, Svendsen UG.

Ugeskr Laeger. 2000 Oct 16;162(42):5648-52. Review. Danish.

PMID:
11059309
6.

[Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects].

ter Meulen CG, Hilbrands LB, van Riemsdijk-van Overbeeke IC, Hené RJ, Christiaans MH, Hoitsma AJ.

Ned Tijdschr Geneeskd. 2000 Dec 9;144(50):2396-400. Review. Dutch.

PMID:
11145094
7.

Daclizumab: a review of its use in the management of organ transplantation.

Carswell CI, Plosker GL, Wagstaff AJ.

BioDrugs. 2001;15(11):745-73. Review.

PMID:
11707149
8.

Induction immunotherapy with IL-2Ra monoclonal antibody in kidney transplantation.

Ahsan N.

Minerva Urol Nefrol. 2003 Mar;55(1):67-79. Review.

PMID:
12773968
9.

Induction therapy: why, when, and which agent?

Krischock L, Marks SD.

Pediatr Transplant. 2010 May;14(3):298-313. doi: 10.1111/j.1399-3046.2009.01290.x. Epub 2010 Mar 23. Review.

PMID:
20345609
10.

The clinical application of monoclonal antibody therapies in renal transplantation.

Dhanireddy KK, Xu H, Mannon RB, Hale DA, Kirk AD.

Expert Opin Emerg Drugs. 2004 May;9(1):23-37. Review.

PMID:
15155134
11.

[Immunosuppressive therapy in renal transplantation].

Nakamura H.

Nihon Hinyokika Gakkai Zasshi. 1993 Aug;84(8):1359-84. Review. Japanese.

12.

Induction therapy in pediatric renal transplant recipients: an overview.

Moudgil A, Puliyanda D.

Paediatr Drugs. 2007;9(5):323-41. Review.

PMID:
17927304
13.

Use of antibody induction in pediatric renal transplantation.

Pescovitz MD.

Curr Opin Organ Transplant. 2008 Oct;13(5):495-9. doi: 10.1097/MOT.0b013e328310b0ba. Review.

PMID:
19060532
14.

Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.

van den Hoogen MW, Hoitsma AJ, Hilbrands LB.

Expert Opin Biol Ther. 2012 Aug;12(8):1031-42. doi: 10.1517/14712598.2012.689278. Epub 2012 May 15. Review.

PMID:
22583145
15.

Use of basiliximab and daclizumab in kidney transplantation.

Olyaei AJ, Thi K, deMattos AM, Bennett WM.

Prog Transplant. 2001 Mar;11(1):33-7; quiz 38-9. Review.

PMID:
11357555
16.

Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation.

Campara M, Tzvetanov IG, Oberholzer J.

Expert Opin Biol Ther. 2010 Jun;10(6):959-69. doi: 10.1517/14712598.2010.485187. Review.

PMID:
20415630
17.

Monoclonal antibody therapy and renal transplantation: focus on adverse effects.

Zaza G, Tomei P, Granata S, Boschiero L, Lupo A.

Toxins (Basel). 2014 Feb 28;6(3):869-91. doi: 10.3390/toxins6030869. Review.

18.

A review of interleukin-2 receptor antagonists in solid organ transplantation.

Berard JL, Velez RL, Freeman RB, Tsunoda SM.

Pharmacotherapy. 1999 Oct;19(10):1127-37. Review.

PMID:
10512062
19.
20.

Use of polyclonal/monoclonal antibody therapies in transplantation.

Yeung MY, Gabardi S, Sayegh MH.

Expert Opin Biol Ther. 2017 Mar;17(3):339-352. doi: 10.1080/14712598.2017.1283400. Epub 2017 Jan 30. Review.

PMID:
28092486

Supplemental Content

Support Center